Andrew Gawman

Andrew Gawman has extensive experience in finance roles in various companies across different industries. Andrew's most recent role as Global Finance Director at Ori Biotech involves enabling patient access to life-saving cell and gene therapies through a proprietary manufacturing platform. Prior to this, Andrew held positions such as CFO at Zentiva UK, EMEA Finance Director at Indivior, and European Pharmaceutical Finance Director at Reckitt Benckiser. Andrew's background includes financial management, business restructuring, and project leadership. Andrew's educational background includes a Bachelor of Arts in Business Studies from Oxford Brookes University.